SOAN - AngioSoma, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
9/29/2018
9/29/2017
Total Revenue
1
1
0
Cost of Revenue
0
0
-
Gross Profit
1
1
-
Operating Expenses
Research Development
-
-
-
Selling General and Administrative
366
352
461
Total Operating Expenses
366
352
461
Operating Income or Loss
-365
-351
-461
Interest Expense
325
103
636
Total Other Income/Expenses Net
-50
-362
-583
Income Before Tax
-739
-817
-1,680
Income Tax Expense
-
-
-
Income from Continuing Operations
-739
-817
-1,680
Net Income
-739
-817
-1,680
Net Income available to common shareholders
-739
-817
-1,680
Reported EPS
Basic
-
-0.01
-0.04
Diluted
-
-0.01
-0.04
Weighted average shares outstanding
Basic
-
56,514
38,972
Diluted
-
56,514
38,972
EBITDA
-
-713
-1,044